- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06692738
Une étude mondiale de phase III sur la chimiothérapie Rilvegostomig ou Pembrolizumab Plus pour le traitement de première intention du cancer épidermoïde métastatique du poumon non à petites cellules (CPNPC)
Une étude mondiale de phase III, randomisée, en double aveugle, multicentrique, sur le rilvegostomig ou le pembrolizumab en association avec une chimiothérapie à base de platine pour le traitement de première intention des patients atteints d'un cancer du poumon épidermoïde non à petites cellules métastatique dont les tumeurs expriment PD-L1 (ARTEMIDE -Poumon02)
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1).
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This is a Phase III, two-arm, randomized, double-blind, global, multicenter study assessing the efficacy and safety of rilvegostomig compared to pembrolizumab, both in combination with platinum-based doublet chemotherapy, as a first-line (1L) treatment for patients with squamous locally advanced or metastatic non-small cell lung cancer (mNSCLC) whose tumors express PD-L1 (tumor cells (TC) ≥ 1%).
Type d'étude
Inscription (Estimé)
Phase
- Phase 3
Contacts et emplacements
Coordonnées de l'étude
- Nom: AstraZeneca Clinical Study Information Center
- Numéro de téléphone: 1-877-240-9479
- E-mail: information.center@astrazeneca.com
Lieux d'étude
-
-
-
Bad Berka, Allemagne, 99437
- Recrutement
- Research Site
-
Berlin, Allemagne, 13125
- Retiré
- Research Site
-
Berlin, Allemagne, 13585
- Retiré
- Research Site
-
Bielefeld, Allemagne, 33611
- Pas encore de recrutement
- Research Site
-
Bochum, Allemagne, 44791
- Pas encore de recrutement
- Research Site
-
Chemnitz, Allemagne, 09116
- Pas encore de recrutement
- Research Site
-
Cologne, Allemagne, 51109
- Recrutement
- Research Site
-
Cologne, Allemagne, 50677
- Pas encore de recrutement
- Research Site
-
Essen, Allemagne, 45136
- Pas encore de recrutement
- Research Site
-
Esslingen am Neckar, Allemagne, 73730
- Recrutement
- Research Site
-
Frankfurt, Allemagne, 60488
- Recrutement
- Research Site
-
Frankfurt am Main, Allemagne, 60431
- Recrutement
- Research Site
-
Gauting, Allemagne, 82131
- Recrutement
- Research Site
-
Giessen, Allemagne, 35392
- Recrutement
- Research Site
-
Großhansdorf, Allemagne, 22927
- Recrutement
- Research Site
-
Halle, Allemagne, 06120
- Pas encore de recrutement
- Research Site
-
Hamburg, Allemagne, 20251
- Recrutement
- Research Site
-
Hamburg, Allemagne, 22087
- Pas encore de recrutement
- Research Site
-
Hanover, Allemagne, 30625
- Recrutement
- Research Site
-
Hanover, Allemagne, 30459
- Recrutement
- Research Site
-
Heidelberg, Allemagne, 69126
- Recrutement
- Research Site
-
Hemer, Allemagne, 58675
- Recrutement
- Research Site
-
Homburg, Allemagne, 66424
- Recrutement
- Research Site
-
Kassel, Allemagne, 34125
- Recrutement
- Research Site
-
Kiel, Allemagne, 24105
- Recrutement
- Research Site
-
Krefeld, Allemagne, 47805
- Recrutement
- Research Site
-
Magdeburg, Allemagne, 39120
- Pas encore de recrutement
- Research Site
-
Minden, Allemagne, 32429
- Recrutement
- Research Site
-
Moers, Allemagne, 47441
- Recrutement
- Research Site
-
München, Allemagne, 81925
- Recrutement
- Research Site
-
Oldenburg i.H., Allemagne, 23758
- Pas encore de recrutement
- Research Site
-
Regensburg, Allemagne, 93053
- Recrutement
- Research Site
-
Schwerin, Allemagne, 19049
- Pas encore de recrutement
- Research Site
-
Velbert, Allemagne, 42551
- Pas encore de recrutement
- Research Site
-
Würzburg, Allemagne, 97067
- Recrutement
- Research Site
-
-
-
-
-
Buenos Aires, Argentine, C1431FWO
- Recrutement
- Research Site
-
CABA, Argentine, 1425
- Recrutement
- Research Site
-
La Plata, Argentine, 1900
- Retiré
- Research Site
-
Pilar, Argentine, B1629ODT
- Recrutement
- Research Site
-
Rosario, Argentine, S2000DEJ
- Recrutement
- Research Site
-
-
-
-
-
Darlinghurst, Australie, 2010
- Recrutement
- Research Site
-
Hyde Park, Australie, 4812
- Recrutement
- Research Site
-
Southport, Australie, 4215
- Recrutement
- Research Site
-
Wollongong, Australie, 2500
- Recrutement
- Research Site
-
-
-
-
-
Anderlecht, Belgique, 1070
- Retiré
- Research Site
-
Brussels, Belgique, 1160
- Recrutement
- Research Site
-
Charleroi, Belgique, 6060
- Recrutement
- Research Site
-
Kortrijk, Belgique, 8500
- Recrutement
- Research Site
-
Ottignies, Belgique, 1340
- Recrutement
- Research Site
-
Sint-Niklaas, Belgique, 9100
- Retiré
- Research Site
-
-
-
-
-
Barretos, Brésil, 14784-400
- Recrutement
- Research Site
-
Florianópolis, Brésil, 88034-000
- Recrutement
- Research Site
-
Ijuí, Brésil, 98700-000
- Recrutement
- Research Site
-
Londrina, Brésil, 86015-520
- Recrutement
- Research Site
-
Porto Alegre, Brésil, 91350-200
- Recrutement
- Research Site
-
Salvador, Brésil, 40050 410
- Recrutement
- Research Site
-
São Paulo, Brésil, 01246-000
- Recrutement
- Research Site
-
São Paulo, Brésil, 05652-900
- Recrutement
- Research Site
-
Taubaté, Brésil, 12030-200
- Retiré
- Research Site
-
-
-
-
New Brunswick
-
Saint John, New Brunswick, Canada, E2L 4L2
- Recrutement
- Research Site
-
-
Nova Scotia
-
Sydney, Nova Scotia, Canada, B1P 1P3
- Recrutement
- Research Site
-
-
Ontario
-
Greater Sudbury, Ontario, Canada, P3E 5J1
- Pas encore de recrutement
- Research Site
-
Hamilton, Ontario, Canada, L8V 1C3
- Recrutement
- Research Site
-
Sault Ste. Marie, Ontario, Canada, P6A 0A8
- Recrutement
- Research Site
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3J1
- Recrutement
- Research Site
-
Montreal, Quebec, Canada, H2X 0A9
- Recrutement
- Research Site
-
-
-
-
-
Beijing, Chine, 100029
- Retiré
- Research Site
-
Beijing, Chine, CN-100730
- Recrutement
- Research Site
-
Beijing, Chine, 100142
- Recrutement
- Research Site
-
Beijing, Chine, 100021
- Recrutement
- Research Site
-
Beijing, Chine, 101149
- Recrutement
- Research Site
-
Changchun, Chine, 130012
- Recrutement
- Research Site
-
Changde, Chine, 415000
- Recrutement
- Research Site
-
Changsha, Chine, 410013
- Recrutement
- Research Site
-
Chengdu, Chine, 610041
- Recrutement
- Research Site
-
Chengdu, Chine, 610072
- Recrutement
- Research Site
-
Chongqing, Chine, 400030
- Recrutement
- Research Site
-
Dalian, Chine, 116001
- Recrutement
- Research Site
-
Guangzhou, Chine, 510062
- Recrutement
- Research Site
-
Guangzhou, Chine, 510100
- Recrutement
- Research Site
-
Hangzhou, Chine, 310003
- Recrutement
- Research Site
-
Hangzhou, Chine, 310022
- Recrutement
- Research Site
-
Hangzhou, Chine, 310016
- Recrutement
- Research Site
-
Harbin, Chine, 150081
- Recrutement
- Research Site
-
Hefei, Chine, 230601
- Recrutement
- Research Site
-
Hefei, Chine, 230001
- Recrutement
- Research Site
-
Jinan, Chine, 250117
- Recrutement
- Research Site
-
Kunming, Chine, 650118
- Recrutement
- Research Site
-
Linhai, Chine, 317000
- Recrutement
- Research Site
-
Linyi, Chine, 276001
- Recrutement
- Research Site
-
Nanchang, Chine, 330008
- Recrutement
- Research Site
-
Ningbo, Chine, 315010
- Recrutement
- Research Site
-
Shanghai, Chine, 200032
- Recrutement
- Research Site
-
Shanghai, Chine, 200030
- Recrutement
- Research Site
-
Shanghai, Chine, 200433
- Recrutement
- Research Site
-
Shenyang, Chine, 110004
- Retiré
- Research Site
-
Shenzhen, Chine, 518020
- Retiré
- Research Site
-
Taiyuan, Chine, 030000
- Recrutement
- Research Site
-
Tianjin, Chine, 300050
- Recrutement
- Research Site
-
Wenzhou, Chine, CN-325000
- Recrutement
- Research Site
-
Wuhan, Chine, 430030
- Recrutement
- Research Site
-
Xi'an, Chine, 710061
- Recrutement
- Research Site
-
Yangzhou, Chine, 225001
- Recrutement
- Research Site
-
Yueyang, Chine, 414000
- Recrutement
- Research Site
-
Zhengzhou, Chine, 450008
- Recrutement
- Research Site
-
Zhengzhou, Chine, 450052
- Recrutement
- Research Site
-
-
-
-
-
Changwon-si, Corée du Sud, 51353
- Recrutement
- Research Site
-
Cheongju-si, Corée du Sud, 28644
- Recrutement
- Research Site
-
Incheon, Corée du Sud, 21565
- Recrutement
- Research Site
-
JinJoo, Corée du Sud, 52727
- Recrutement
- Research Site
-
Seoul, Corée du Sud, 03080
- Recrutement
- Research Site
-
Seoul, Corée du Sud, 06351
- Recrutement
- Research Site
-
Seoul, Corée du Sud, 05505
- Recrutement
- Research Site
-
Seoul, Corée du Sud, 03722
- Recrutement
- Research Site
-
Suwon, Corée du Sud, 16247
- Recrutement
- Research Site
-
Suwon, Corée du Sud, 16499
- Recrutement
- Research Site
-
-
-
-
-
Almería, Espagne, 04009
- Pas encore de recrutement
- Research Site
-
Barcelona, Espagne, 8035
- Recrutement
- Research Site
-
Las Palmas de Gran Canaria, Espagne, 35016
- Recrutement
- Research Site
-
Lleida, Espagne, 25198
- Recrutement
- Research Site
-
Madrid, Espagne, 28007
- Recrutement
- Research Site
-
Madrid, Espagne, 28034
- Recrutement
- Research Site
-
Majadahonda, Espagne, 28222
- Recrutement
- Research Site
-
Seville, Espagne, 41013
- Recrutement
- Research Site
-
-
-
-
-
Avignon, France, 84902
- Recrutement
- Research Site
-
La Rochelle, France, 17019
- Recrutement
- Research Site
-
Lyon, France, 69008
- Recrutement
- Research Site
-
Nîmes, France, 30029
- Recrutement
- Research Site
-
Rennes, France, 35033
- Recrutement
- Research Site
-
Strasbourg, France, 67091
- Recrutement
- Research Site
-
Suresnes, France, 92150
- Recrutement
- Research Site
-
Toulon, France, 83800
- Recrutement
- Research Site
-
-
-
-
-
Budapest, Hongrie, 1121
- Recrutement
- Research Site
-
Budapest, Hongrie, 1083
- Recrutement
- Research Site
-
Budapest, Hongrie, 1122
- Recrutement
- Research Site
-
Debrecen, Hongrie, 4032
- Recrutement
- Research Site
-
Edelény, Hongrie, 3780
- Pas encore de recrutement
- Research Site
-
Gyöngyös, Hongrie, 3200
- Retiré
- Research Site
-
Gyöngyös - Mátraháza, Hongrie, 3200
- Recrutement
- Research Site
-
Győr, Hongrie, 9024
- Recrutement
- Research Site
-
Pécs, Hongrie, 7624
- Recrutement
- Research Site
-
Székesfehérvár, Hongrie, 8000
- Suspendu
- Research Site
-
Törökbálint, Hongrie, 2045
- Recrutement
- Research Site
-
-
-
-
-
Calicut, Inde, 673601
- Recrutement
- Research Site
-
Delhi, Inde, 110029
- Recrutement
- Research Site
-
Gūrgaon, Inde, 122001
- Recrutement
- Research Site
-
Kolkata, Inde, 700054
- Retiré
- Research Site
-
Madurai, Inde, 625107
- Recrutement
- Research Site
-
Mumbai, Inde, 400012
- Pas encore de recrutement
- Research Site
-
Nagpur, Inde, 440001
- Pas encore de recrutement
- Research Site
-
Nashik, Inde, 422002
- Recrutement
- Research Site
-
New Delhi, Inde, 110075
- Retiré
- Research Site
-
Puducherry, Inde, 605006
- Retiré
- Research Site
-
Surat, Inde, 395017
- Recrutement
- Research Site
-
Varanasi, Inde, 221005
- Recrutement
- Research Site
-
-
-
-
-
Florence, Italie, 50134
- Recrutement
- Research Site
-
Legnano, Italie, 20025
- Pas encore de recrutement
- Research Site
-
Livorno, Italie, 57126
- Pas encore de recrutement
- Research Site
-
Monza, Italie, 20900
- Recrutement
- Research Site
-
Orbassano, Italie, 10043
- Recrutement
- Research Site
-
Padova, Italie, 35128
- Recrutement
- Research Site
-
Peschiera del Garda, Italie, 37019
- Recrutement
- Research Site
-
Roma, Italie, 00168
- Recrutement
- Research Site
-
-
-
-
-
Amagasaki-shi, Japon, 660-8550
- Recrutement
- Research Site
-
Bunkyō City, Japon, 113-8603
- Recrutement
- Research Site
-
Chūōku, Japon, 104-0045
- Recrutement
- Research Site
-
Fukuoka, Japon, 812-8582
- Recrutement
- Research Site
-
Fukuoka, Japon, 814-0180
- Recrutement
- Research Site
-
Hirakata-shi, Japon, 573-1191
- Pas encore de recrutement
- Research Site
-
Hiroshima, Japon, 734-8551
- Recrutement
- Research Site
-
Kakogawa-shi, Japon, 675-8611
- Pas encore de recrutement
- Research Site
-
Kanazawa, Japon, 920-8530
- Recrutement
- Research Site
-
Kawagoe-shi, Japon, 350-8550
- Recrutement
- Research Site
-
Kawasaki-shi, Japon, 216-8511
- Recrutement
- Research Site
-
Kitaadachi-gun, Japon, 362-0806
- Recrutement
- Research Site
-
Kitakyushu-shi, Japon, 807-8555
- Recrutement
- Research Site
-
Kiyose-shi, Japon, 204-8522
- Pas encore de recrutement
- Research Site
-
Kobe, Japon, 650-0017
- Recrutement
- Research Site
-
Kumamoto, Japon, 861-4193
- Recrutement
- Research Site
-
Kumamoto, Japon, 860-8556
- Recrutement
- Research Site
-
Kyoto, Japon, 612-8555
- Recrutement
- Research Site
-
Kōtoku, Japon, 135-8550
- Recrutement
- Research Site
-
Matsusaka-shi, Japon, 515-8544
- Recrutement
- Research Site
-
Obihiro-shi, Japon, 080-0024
- Pas encore de recrutement
- Research Site
-
Osaka, Japon, 541-8567
- Recrutement
- Research Site
-
Ota-shi, Japon, 373-8550
- Recrutement
- Research Site
-
Saitama-shi, Japon, 338-0001
- Recrutement
- Research Site
-
Sakai, Japon, 590-0197
- Recrutement
- Research Site
-
Sapporo, Japon, 006-8555
- Recrutement
- Research Site
-
Sendai, Japon, 981-0914
- Recrutement
- Research Site
-
Shinjuku-ku, Japon, 160-0023
- Recrutement
- Research Site
-
Takaoka-shi, Japon, 933-8555
- Recrutement
- Research Site
-
Yokohama, Japon, 241-8515
- Recrutement
- Research Site
-
Yokohama, Japon, 232-0024
- Recrutement
- Research Site
-
-
-
-
-
Innsbruck, L'Autriche, 6020
- Recrutement
- Research Site
-
Krems, L'Autriche, 3500
- Recrutement
- Research Site
-
Rankweil, L'Autriche, 6830
- Recrutement
- Research Site
-
Vienna, L'Autriche, 1210
- Recrutement
- Research Site
-
Vienna, L'Autriche, 1160
- Recrutement
- Research Site
-
-
-
-
-
George Town, Malaisie, 10450
- Recrutement
- Research Site
-
Johor Bahru, Malaisie, 81100
- Recrutement
- Research Site
-
Kuala Lumpur, Malaisie, 59100
- Recrutement
- Research Site
-
-
-
-
-
Alkmaar, Pays-Bas, 1815 JD
- Recrutement
- Research Site
-
Ede, Pays-Bas, 6716 RP
- Recrutement
- Research Site
-
Groningen, Pays-Bas, 9713 GZ
- Retiré
- Research Site
-
Leidschendam, Pays-Bas, 2262 BA
- Recrutement
- Research Site
-
Veldhoven, Pays-Bas, 5504 DB
- Recrutement
- Research Site
-
Zwolle, Pays-Bas, 8025 AB
- Recrutement
- Research Site
-
-
-
-
-
Bialystok, Pologne, 15-027
- Retiré
- Research Site
-
Biała Podlaska, Pologne, 21-500
- Retiré
- Research Site
-
Bydgoszcz, Pologne, 85-796
- Retiré
- Research Site
-
Bystra, Pologne, 43-360
- Recrutement
- Research Site
-
Lodz, Pologne, 93-338
- Recrutement
- Research Site
-
Lublin, Pologne, 20-090
- Pas encore de recrutement
- Research Site
-
Poznan, Pologne, 60-569
- Recrutement
- Research Site
-
Warsaw, Pologne, 04-141
- Recrutement
- Research Site
-
Wroclaw, Pologne, 53-413
- Recrutement
- Research Site
-
-
-
-
-
San Juan, Porto Rico, 00918
- Recrutement
- Research Site
-
San Juan, Porto Rico, 00909
- Recrutement
- Research Site
-
-
-
-
-
Lima, Pérou, L27
- Retiré
- Research Site
-
Lima, Pérou, 15036
- Retiré
- Research Site
-
Lima, Pérou, LIMA 29
- Retiré
- Research Site
-
Lima, Pérou, 15102
- Retiré
- Research Site
-
Lima, Pérou, 34
- Retiré
- Research Site
-
Lima, Pérou, Lima39
- Retiré
- Research Site
-
-
-
-
-
Aberdeen, Royaume-Uni, AB25 2ZN
- Recrutement
- Research Site
-
Cambridge, Royaume-Uni, CB2 0QQ
- Recrutement
- Research Site
-
Edinburgh, Royaume-Uni, EH4 2XU
- Recrutement
- Research Site
-
Exeter, Royaume-Uni, EX2 5DW
- Retiré
- Research Site
-
Greater London, Royaume-Uni, SW3 6JJ
- Recrutement
- Research Site
-
London, Royaume-Uni, EC1A 7BE
- Recrutement
- Research Site
-
London, Royaume-Uni, SE1 9RT
- Recrutement
- Research Site
-
Manchester, Royaume-Uni, M20 4BX
- Recrutement
- Research Site
-
Newcastle upon Tyne, Royaume-Uni, NE7 7AF
- Recrutement
- Research Site
-
Preston, Royaume-Uni, PR2 9HT
- Recrutement
- Research Site
-
-
-
-
-
Kaohsiung City, Taïwan, 80756
- Recrutement
- Research Site
-
Kaohsiung City, Taïwan, 824
- Recrutement
- Research Site
-
New Taipei City, Taïwan, 220
- Recrutement
- Research Site
-
New Taipei City, Taïwan, 23561
- Recrutement
- Research Site
-
Taichung, Taïwan, 40705
- Recrutement
- Research Site
-
Taichung, Taïwan, 402
- Recrutement
- Research Site
-
Tainan, Taïwan, 73657
- Recrutement
- Research Site
-
Taoyuan, Taïwan, 333
- Recrutement
- Research Site
-
-
-
-
-
Bangkok, Thaïlande, 10700
- Recrutement
- Research Site
-
Chiang Mai, Thaïlande, 50200
- Recrutement
- Research Site
-
Dusit, Thaïlande, 10300
- Recrutement
- Research Site
-
Nakhon Ratchasima, Thaïlande, 30000
- Recrutement
- Research Site
-
Songkhla, Thaïlande, 90110
- Recrutement
- Research Site
-
-
-
-
-
Ankara, Turquie (Türkiye), 6500
- Recrutement
- Research Site
-
Antalya, Turquie (Türkiye), 07059
- Recrutement
- Research Site
-
Istanbul, Turquie (Türkiye), 34098
- Recrutement
- Research Site
-
Yenimahalle, Turquie (Türkiye), 06170
- Recrutement
- Research Site
-
-
-
-
-
Can Tho, Viêt Nam, 900000
- Recrutement
- Research Site
-
Hanoi, Viêt Nam, 100000
- Recrutement
- Research Site
-
Ho Chi Minh City, Viêt Nam, 700000
- Recrutement
- Research Site
-
Vinh, Viêt Nam, 460000
- Recrutement
- Research Site
-
-
-
-
Arizona
-
Tucson, Arizona, États-Unis, 85724
- Recrutement
- Research Site
-
-
Arkansas
-
Springdale, Arkansas, États-Unis, 72762
- Recrutement
- Research Site
-
-
California
-
Anaheim, California, États-Unis, 92801
- Recrutement
- Research Site
-
Beverly Hills, California, États-Unis, 90211
- Recrutement
- Research Site
-
Loma Linda, California, États-Unis, 92354
- Recrutement
- Research Site
-
Los Alamitos, California, États-Unis, 90720
- Recrutement
- Research Site
-
Redlands, California, États-Unis, 92373
- Recrutement
- Research Site
-
San Francisco, California, États-Unis, 94121
- Recrutement
- Research Site
-
Walnut Creek, California, États-Unis, 94598
- Recrutement
- Research Site
-
-
Connecticut
-
West Haven, Connecticut, États-Unis, 06516
- Recrutement
- Research Site
-
-
Delaware
-
Newark, Delaware, États-Unis, 19713
- Recrutement
- Research Site
-
-
Florida
-
Bay Pines, Florida, États-Unis, 33744
- Recrutement
- Research Site
-
Fort Lauderdale, Florida, États-Unis, 33308
- Recrutement
- Research Site
-
Gainesville, Florida, États-Unis, 32610
- Retiré
- Research Site
-
Gainesville, Florida, États-Unis, 32608
- Recrutement
- Research Site
-
Jacksonville, Florida, États-Unis, 32224
- Recrutement
- Research Site
-
-
Georgia
-
Athens, Georgia, États-Unis, 30607
- Recrutement
- Research Site
-
Atlanta, Georgia, États-Unis, 30341
- Retiré
- Research Site
-
Savannah, Georgia, États-Unis, 31404
- Pas encore de recrutement
- Research Site
-
-
Idaho
-
Boise, Idaho, États-Unis, 83712
- Recrutement
- Research Site
-
-
Illinois
-
Chicago, Illinois, États-Unis, 60637
- Recrutement
- Research Site
-
Decatur, Illinois, États-Unis, 62526
- Recrutement
- Research Site
-
Hinsdale, Illinois, États-Unis, 60521
- Recrutement
- Research Site
-
Quincy, Illinois, États-Unis, 62301
- Recrutement
- Research Site
-
Rockford, Illinois, États-Unis, 61114
- Retiré
- Research Site
-
-
Indiana
-
Fort Wayne, Indiana, États-Unis, 46845
- Pas encore de recrutement
- Research Site
-
-
Iowa
-
Waterloo, Iowa, États-Unis, 50702
- Recrutement
- Research Site
-
-
Kentucky
-
Lexington, Kentucky, États-Unis, 40509
- Recrutement
- Research Site
-
Lexington, Kentucky, États-Unis, 40536
- Retiré
- Research Site
-
Louisville, Kentucky, États-Unis, 40207
- Recrutement
- Research Site
-
Louisville, Kentucky, États-Unis, 40202
- Recrutement
- Research Site
-
-
Louisiana
-
Alexandria, Louisiana, États-Unis, 71301
- Retiré
- Research Site
-
Baton Rouge, Louisiana, États-Unis, 70808
- Recrutement
- Research Site
-
Covington, Louisiana, États-Unis, 70433
- Retiré
- Research Site
-
Shreveport, Louisiana, États-Unis, 71105
- Recrutement
- Research Site
-
Shreveport, Louisiana, États-Unis, 71103
- Recrutement
- Research Site
-
-
Maine
-
Scarborough, Maine, États-Unis, 04074
- Recrutement
- Research Site
-
-
Maryland
-
Baltimore, Maryland, États-Unis, 21202
- Complété
- Research Site
-
Bethesda, Maryland, États-Unis, 20817
- Recrutement
- Research Site
-
Bethesda, Maryland, États-Unis, 20889
- Pas encore de recrutement
- Research Site
-
-
Michigan
-
Detroit, Michigan, États-Unis, 48202
- Recrutement
- Research Site
-
Grand Rapids, Michigan, États-Unis, 49503
- Recrutement
- Research Site
-
Saginaw, Michigan, États-Unis, 48602
- Pas encore de recrutement
- Research Site
-
-
Minnesota
-
Duluth, Minnesota, États-Unis, 55802
- Recrutement
- Research Site
-
Rochester, Minnesota, États-Unis, 55905
- Recrutement
- Research Site
-
-
Missouri
-
Bridgeton, Missouri, États-Unis, 63044
- Recrutement
- Research Site
-
Columbia, Missouri, États-Unis, 65212
- Retiré
- Research Site
-
Kansas City, Missouri, États-Unis, 64108
- Recrutement
- Research Site
-
-
Nebraska
-
Lincoln, Nebraska, États-Unis, 68506
- Recrutement
- Research Site
-
-
New Jersey
-
Camden, New Jersey, États-Unis, 08103
- Recrutement
- Research Site
-
-
New York
-
Buffalo, New York, États-Unis, 14221
- Recrutement
- Research Site
-
East Syracuse, New York, États-Unis, 13057
- Recrutement
- Research Site
-
Westbury, New York, États-Unis, 11590
- Recrutement
- Research Site
-
-
North Carolina
-
Wilson, North Carolina, États-Unis, 27893
- Recrutement
- Research Site
-
-
North Dakota
-
Grand Forks, North Dakota, États-Unis, 58201
- Recrutement
- Research Site
-
-
Ohio
-
Cincinnati, Ohio, États-Unis, 45267
- Recrutement
- Research Site
-
-
Oregon
-
Bend, Oregon, États-Unis, 97701
- Retiré
- Research Site
-
Medford, Oregon, États-Unis, 97504
- Recrutement
- Research Site
-
Salem, Oregon, États-Unis, 97301
- Recrutement
- Research Site
-
-
Pennsylvania
-
Hershey, Pennsylvania, États-Unis, 17033
- Recrutement
- Research Site
-
York, Pennsylvania, États-Unis, 17403
- Recrutement
- Research Site
-
-
South Dakota
-
Sioux Falls, South Dakota, États-Unis, 57105
- Recrutement
- Research Site
-
-
Tennessee
-
Chattanooga, Tennessee, États-Unis, 37404
- Recrutement
- Research Site
-
Nashville, Tennessee, États-Unis, 37203
- Recrutement
- Research Site
-
-
Texas
-
Fort Worth, Texas, États-Unis, 76104
- Recrutement
- Research Site
-
Houston, Texas, États-Unis, 77090
- Complété
- Research Site
-
Kingwood, Texas, États-Unis, 77339
- Recrutement
- Research Site
-
Lubbock, Texas, États-Unis, 79410
- Recrutement
- Research Site
-
Round Rock, Texas, États-Unis, 78665
- Recrutement
- Research Site
-
-
Virginia
-
Fairfax, Virginia, États-Unis, 22031
- Recrutement
- Research Site
-
Fredericksburg, Virginia, États-Unis, 22408
- Recrutement
- Research Site
-
-
Washington
-
Olympia, Washington, États-Unis, 98506
- Recrutement
- Research Site
-
Seattle, Washington, États-Unis, 98101
- Recrutement
- Research Site
-
Silverdale, Washington, États-Unis, 98383
- Retiré
- Research Site
-
Spokane, Washington, États-Unis, 99208
- Recrutement
- Research Site
-
Tacoma, Washington, États-Unis, 98405
- Recrutement
- Research Site
-
Wenatchee, Washington, États-Unis, 98801
- Retiré
- Research Site
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Histologically or cytologically documented squamous NSCLC.
- Stage III B/C or IV mNSCLC (based on the American Joint Committee on Cancer Edition 8) not amenable to curative treatment.
- Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any actionable driver oncogenes for which there are locally approved and available targeted 1L therapies.
- Provision of acceptable tumor sample to confirm tumor PD-L1 expression TC ≥ 1%.
- At least one lesion not previously irradiated that qualifies as a RECIST 1.1 TL at baseline and can be accurately measured at baseline as ≥ 10 mm in the longest diameter (except lymph nodes, which must have short axis ≥ 15 mm) with CT or MRI and is suitable for accurate repeated measurements.
- Adequate organ and bone marrow function.
Exclusion Criteria:
- Presence of small cell and neuroendocrine histology components.
- Brain metastases unless asymptomatic, stable, and not requiring steroids or anticonvulsants for at least 7 days prior to randomization. A minimum of 2 weeks must have elapsed between the end of local therapy (brain radiotherapy or surgery) and randomization. Participants must have recovered from the acute toxic effect of radiotherapy (eg, dizziness and signs of increased intracranial pressure) or surgery prior to randomization.
- Any prior systemic, non-curative therapy received for NSCLC.
- Any prior treatment with an anti-PD-1 or anti-PD-L1 agent.
- Any prior exposure to an anti-TIGIT therapy or any other anticancer therapy targeting immune-regulatory receptors or mechanisms.
- History of another primary malignancy except for malignancy treated with curative intent with no known active disease ≥ 2 years before the first dose of study intervention and of low potential risk for recurrence.
- Active or prior documented autoimmune or inflammatory disorders requiring chronic systemic treatment with the use of disease-modifying agents or other immunosuppressive drugs.
- Active primary immunodeficiency/active infectious disease(s).
- Active tuberculosis infection.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Arm A
Rilvegostomig in combination with carboplatin and paclitaxel or nab-paclitaxel followed by rilvegostomig |
Administered intravenously (IV) on Day 1 of each 21-day cycle
Autres noms:
Administered intravenously (IV) on Day 1 of each 21-day cycle up to 4 cycles Administered intravenously (IV) on Day 1 of each 21-day cycle up to 4 cycles Administered intravenously (IV) on Days 1, 8, and 15 of each 21-day cycle up to 4 cycles |
|
Comparateur actif: Arm B
Pembrolizumab in combination with carboplatin and paclitaxel or nab-paclitaxel followed by pembrolizumab |
Administered intravenously (IV) on Day 1 of each 21-day cycle up to 4 cycles Administered intravenously (IV) on Day 1 of each 21-day cycle up to 4 cycles Administered intravenously (IV) on Days 1, 8, and 15 of each 21-day cycle up to 4 cycles Administered intravenously (IV) on Day 1 of each 21-day cycle
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Overall survival (OS)
Délai: Up to approximately 6 years
|
OS is defined as the time from randomization until the date of death due to any cause. |
Up to approximately 6 years
|
|
Progression-free survival (PFS)
Délai: Up to approximately 6 years
|
PFS is defined as the time from randomization until radiological progression per Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST 1.1) or death due to any cause (in the absence of progression). |
Up to approximately 6 years
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Landmark overall survival (OS) rates
Délai: Up to approximately 6 years
|
OS is defined as the time from randomization until the date of death due to any cause. |
Up to approximately 6 years
|
|
Landmark progression-free survival (PFS) rates
Délai: Up to approximately 6 years
|
PFS is defined as the time from randomization until radiological progression per Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST 1.1) or death due to any cause (in the absence of progression). |
Up to approximately 6 years
|
|
Time to second progression or death (PFS2)
Délai: Up to approximately 6 years
|
PFS2 is defined as the time from randomization until the earliest of the progression event (following the initial progression event), after the start of the first subsequent therapy, or death from any cause, whichever occurs first. The date of the second progression will be recorded by the investigator in the electronic Case Report Form (eCRF) and defined according to local standard clinical practice. |
Up to approximately 6 years
|
|
Overall response rate (ORR)
Délai: Up to approximately 6 years
|
ORR is defined as the proportion of participants who have a confirmed complete response (CR) or confirmed partial response (PR), by using Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST 1.1). |
Up to approximately 6 years
|
|
Duration of response (DoR)
Délai: Up to approximately 6 years
|
DoR is defined as the time from the date of first documented response until the date of documented progression using Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST 1.1) or death due to any cause (in the absence of progression). |
Up to approximately 6 years
|
|
Pharmacokinetic (PK) of rilvegostomig
Délai: Up to approximately 6 years
|
Concentration of rilvegostomig in serum. |
Up to approximately 6 years
|
|
Immunogenicity of rilvegostomig
Délai: Up to approximately 6 years
|
Presence of antidrug antibodies (ADAs), titer, and neutralizing antibodies for rilvegostomig. |
Up to approximately 6 years
|
|
Patient-reported physical functioning
Délai: Up to approximately 6 years
|
Proportion of participants with maintained or improved physical functioning as measured by Patient-Reported Outcomes Measurement Information System Physical Function - Short Form 8c - 7 day (PROMIS PF-SF 8c - 7 day) at each time point. |
Up to approximately 6 years
|
|
Patient-reported global health status (GHS)/quality of life (QoL)
Délai: Up to approximately 6 years
|
Time to deterioration (TTD) of GHS/QoL as measured by the European Organization for Research and Treatment of Cancer Item Library 172 (EORTC IL172). TTD is defined as time from randomization to the date of first deterioration. Deterioration is defined as a worsening change from baseline that reaches a clinically meaningful change threshold. |
Up to approximately 6 years
|
|
Patient-reported lung cancer symptoms of non-small cell lung cancer (NSCLC)
Délai: Up to approximately 6 years
|
Time to deterioration (TTD) in pulmonary symptoms as measured by the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ). TTD is defined as time from randomization to the date of first deterioration. |
Up to approximately 6 years
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
- Pembrolizumab
- Carboplatine
- Cancer du poumon non à petites cellules (NSCLC)
- Paclitaxel
- Nab-paclitaxel
- Anticorps bi-spécifique
- Mort programmée-ligand 1 (PD-L1)
- Rilvégostomig (AZD2936)
- Domaine de motif inhibiteur basé sur l'immunoglobuline des lymphocytes T et la tyrosine des immunorécepteurs (TIGIT)
- ARTEMIDE-Poumon02
Termes MeSH pertinents supplémentaires
- Tumeurs par site
- Tumeurs
- Maladies des voies respiratoires
- Maladies pulmonaires
- Tumeurs des voies respiratoires
- Tumeurs thoraciques
- Tumeurs pulmonaires
- Carcinome bronchique
- Tumeurs bronchiques
- Carcinome pulmonaire non à petites cellules
- Produits chimiques organiques
- Hydrocarbures
- Cycloparaffines
- Hydrocarbures, alicyclique
- Hydrocarbures, cyclique
- Terpènes
- Complexes de coordination
- Taxes
- Cyclodécanes
- Diterpènes
- Carboplatine
- Paclitaxel
- pembrolizumab
- Paclitaxel lié à l'albumine de 130 nm
Autres numéros d'identification d'étude
- D702BC00001
- 2024-514281-39-00 (Identificateur de registre: CTIS (EU))
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca (AZ) group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment:
https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure. "Yes", indicates that AZ are accepting requests for Important Protocol Deviation (IPD), but this does not mean all requests will be approved.
Délai de partage IPD
AstraZeneca will meet or exceed data availability as per the commitments made to the European Federation of Pharmaceutical Industries and Associations (EFPIA)/Pharmaceutical Research and Manufacturers of America (PhRMA) Data-Sharing Principles. For details of our timelines, please refer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure
Critères d'accès au partage IPD
When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. A Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .